Related Experiment Video

Updated: Jul 8, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

The New Way to Define Key Oncogenic Drivers of Small Cell Lung Cancer

Kee-Beom Kim1

  • 1BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea.

Development & Reproduction
|December 11, 2023
PubMed

Insights

Small-cell lung cancer (SCLC) remains deadly due to therapy resistance. Genomic analysis reveals key mutations like RB and P53 loss, offering new therapeutic targets for this challenging disease.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Small-cell lung cancer (SCLC) has a high mortality rate, largely due to acquired resistance to current chemo/radiotherapies.
  • Standard SCLC treatments have not advanced in 30 years, highlighting an urgent need for novel therapeutic strategies.
  • Understanding SCLC's molecular underpinnings is crucial for developing effective treatments.

Purpose of the Study:

  • To identify somatic alterations in the SCLC genome.
  • To understand the molecular determinants driving SCLC development and resistance.
  • To discover new therapeutic vulnerabilities and targets based on genomic findings.

Main Methods:

  • Genomic analysis of SCLC samples to identify somatic alterations.
  • Utilizing new techniques to investigate the molecular mechanisms of SCLC.
  • Focusing on understanding the genetic landscape of SCLC.

Main Results:

  • SCLC genome exhibits numerous somatic alterations with significant mutational heterogeneity.
  • Consistent loss of both RB and P53 tumor suppressor genes (TSGs) was observed across SCLC samples.
  • New techniques enabled the determination of underlying mechanisms for therapeutic target discovery.

Conclusions:

  • Identifying specific genomic alterations in SCLC is key to understanding disease mechanisms.
  • The consistent loss of RB and P53 TSGs represents a critical vulnerability in SCLC.
  • Genomic insights are paving the way for novel therapeutic strategies against SCLC.
Keywords:
Clustered regularly interspaced short palindromic repeats (CRISPR)Small-cell lung cancer (SCLC)Somatic engineering mouse modelpre-cancerous cells (preSC)

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.0K

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K